iSAYSO
Contribute

FARQ-ACC-INS-005 — COVID-19 Treatment Injury, Crown Indemnity and Non-ACC Recovery Pathways

Share on FacebookShare on XInteractive reader

COVID-19 VACCINATION: TREATMENT INJURY, CROWN INDEMNITY
AND NON-ACC RECOVERY PATHWAYS

Official Information Request / Insurance & Indemnity Evidence Register

Reference

FARQ-ACC-INS-005

Date

21 September 2026

To

Accident Compensation Corporation (ACC)

Subject

COVID-19 vaccination treatment injury, compensation, Crown indemnity and private-insurance coordination

Series

Insurance & Indemnity Evidence Register

Purpose of this request

This request seeks existing records sufficient to trace the financial and legal pathway where a person suffered an alleged injury or death following COVID-19 vaccination. It is directed particularly to the relationship between ACC treatment-injury cover, Crown/supplier indemnities, recovery from third parties, and contractual private-insurance benefits. It does not ask ACC to determine whether any particular individual claim is valid.

CENTRAL QUESTION: Where a COVID-19 vaccination injury or death is alleged, what payment and recovery routes exist, who bears the financial liability, and how does ACC interact with Crown indemnities, vaccine suppliers and private insurance?

1. Current claim pathway

1. Provide the current policy, procedure, guidance, flowchart and forms used to lodge and assess a treatment-injury claim arising from vaccination, including COVID-19 vaccination.
2. Identify the evidence ordinarily required to establish personal injury and causation, and the process for obtaining clinical or specialist advice.
3. Identify the process where symptoms, diagnosis or causal evidence emerge months or years after vaccination, including any process for a new claim, reassessment, review or reopening.
4. Identify the review and appeal routes available following a declined or partially accepted claim.

2. COVID-19 vaccination treatment-injury data

For the period 18 February 2021 to the date of response, provide aggregate data, preferably by calendar or financial year, showing:

5. claims lodged, accepted, declined, withdrawn and awaiting decision;
6. accepted injury/diagnosis categories and declined injury/diagnosis categories, at a level that does not identify individuals;
7. claims involving death, and the number accepted and declined;
8. claims resulting in weekly compensation, treatment costs, rehabilitation, lump-sum/permanent-impairment compensation, funeral grants or survivor/dependant entitlements, where recorded;
9. aggregate amount paid for COVID-19 vaccination treatment-injury claims, broken down by entitlement type where reasonably available;
10. decisions taken to review or appeal and the number altered, overturned or returned for reconsideration.

3. Funding account and financial allocation

11. Identify the ACC Account or funding source from which COVID-19 vaccination treatment-injury liabilities and entitlements are paid.
12. Provide any final briefing, accounting guidance or policy describing how these costs are allocated, forecast or reported.
13. Provide aggregate annual expenditure and outstanding liability/provision, if held, for COVID-19 vaccination treatment-injury claims.

4. Crown indemnities and supplier recovery

The Ministry of Health has publicly confirmed that the Crown granted indemnities to COVID-19 vaccine suppliers. In relation to information held by ACC, please provide:

14. any policy, memorandum, briefing, correspondence or agreement addressing whether ACC may seek recovery, contribution or reimbursement from a COVID-19 vaccine supplier, the Crown, or another indemnified party for treatment-injury costs;
15. whether ACC has notified any COVID-19 vaccination treatment-injury claim, class of claims, expenditure or potential liability to the Ministry of Health, Treasury, Crown Law, Pharmac, a vaccine supplier, insurer, indemnity administrator or other Crown entity for recovery or contribution purposes;
16. aggregate number and value of any such recoveries, contributions, reimbursements or payments received, if any;
17. if no recovery route exists, provide the policy, legal advice summary or other record sufficient to identify why ACC bears the relevant cost without supplier recovery.

5. Private insurance and contractual benefits

18. Provide any ACC policy, operational guidance, memorandum or public guidance concerning interaction between ACC treatment-injury entitlements and private health, life, trauma/critical-illness, income-protection, mortgage-protection, total-and-permanent-disability, key-person or employer group insurance.
19. Identify which ACC entitlements, if any, are affected by private-insurance payments and the statutory or policy basis for that treatment.
20. Identify whether ACC requires or requests a claimant to disclose private-insurance benefits, and for what purpose.
21. Provide any agreements, memoranda of understanding or standard information-sharing arrangements held by ACC with private insurers or industry bodies concerning treatment-injury claims or benefit coordination.
22. Identify any guidance held by ACC concerning insurers requiring a claimant to seek an ACC decision before determining a private contractual claim.

6. Death and dependant claims

23. Provide the current process and criteria where death is alleged to have resulted from a COVID-19 vaccination treatment injury.
24. Identify the entitlements potentially available to a spouse/partner, child or other dependant where cover is accepted.
25. Provide any policy addressing the interaction between those entitlements and a deceased person’s private life, mortgage, income-protection or employer group insurance benefits.

7. Causation guidance and changes over time

26. Provide the versions, with effective dates, of ACC guidance specifically used to assess COVID-19 or mRNA vaccine treatment-injury claims.
27. Identify material changes to that guidance and the reason recorded for each change.
28. Provide any final guidance or briefing addressing myocarditis/pericarditis or other adverse events specifically recognised for claim-assessment purposes.
29. Identify the process for reconsidering an earlier decline where later medical or scientific evidence materially changes the causation assessment.

8. Information not held by ACC

If information responsive to any part of this request is believed to be held by another agency, please transfer that part under section 14 of the Official Information Act 1982 and identify the agency and part transferred. If ACC does not hold the information and has no grounds for believing another agency holds it, please state that expressly.

9. Response format and evidential integrity

30. Please answer each numbered item separately.
31. Where a document is relied upon, provide its title, date, author/office and reference number together with a copy or direct public link.
32. For aggregate data, machine-readable CSV or spreadsheet format is preferred where available.
33. Personal identifying information is not sought. Aggregate or de-identified information is sufficient.
34. If information is withheld, identify the specific statutory ground relied upon and the public-interest balancing undertaken where applicable.
35. Please preserve the original metadata and document references for material supplied electronically.

Existing official context

This request follows published official material confirming that ACC treats a qualifying physical injury caused by vaccination as a potential treatment injury, and that accepted claims may attract treatment, rehabilitation and compensation. ACC has also published periodic COVID-19 vaccination treatment-injury claim data. Separately, the Ministry of Health has publicly confirmed that the Crown granted indemnities to COVID-19 vaccine suppliers. This request seeks to connect those presently separate financial records and identify the complete recovery pathway.

Requested outcome

The requested records should enable an affected person or family to determine, without speculation, which statutory and contractual recovery pathways may exist, what evidence is required, who receives a claim, who ultimately bears the financial cost, and whether any recovery from an indemnified supplier or other party is available.

For: FARQ / We Review the Crown / isayso.net

Evidence and accountability record – NOT A LAWYER